U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06984835) titled 'Safety and Effectiveness of ELLANSE(R)-S Dermal Filler in the Treatment of Nasolabial Folds' on April 28.
Brief Summary: The study will be a prospective, randomized, multi-center, split-face, controlled, double-blind clinical trial to evaluate the safety and effectiveness of ELLANSE(R)-S for the treatment of NLFs. Subjects will be randomized to receive treatment (ELLANSE(R)-S) in one NLF and control (Radiesse(R)) in the contralateral NLF. A total of 126 subjects will be treated. The control and test articles will be supplied in sterile ready-to-use, pre-filled syringes. Initial treatment and any 4-week touch-up will be done consisten...